AMJ New Editor-in-Chief Announcement
News

AMJ New Editor-in-Chief Announcement

Editorial Office

AME Publishing Company

Correspondence to: Editorial Office. AME Publishing Company. Email: amj@amegroups.com.

Received: 21 February 2020; Accepted: 24 February 2020; Published: 25 March 2020.

doi: 10.21037/amj.2020.02.10


The editorial office of AME Medical Journal (AMJ) is pleased to announce that, effective March 2020, Dr. Philippe E. Spiess (Figure 1) will be taking over as the co-Editor-in-Chief of AME Medical Journal in tandem with Dr. Yaxing Shen and Dr. Xingshun Qi.

Figure 1 Dr. Philippe E. Spiess.

Dr. Philippe E. Spiess is presently a Senior Member in the Department of Genitourinary Oncology and the Department of Tumor Biology at the H. Lee Moffitt Cancer Center and Research Institute. Similarly he serves as the Assistant Chief of Surgery in addition to several other administrative responsibilities that enhance the quality of care provided to patients at the cancer center. Furthermore, he is also full Professor in the Department of Oncologic Sciences at the University of South Florida, College of Medicine.

As a native of Canada, Dr. Spiess received a master’s in Experimental Urology surgery at McGill University in 1995 and his medical degree from the University of Toronto in 1999. Dr. Spiess completed a three-year SUO-accredited urologic oncology fellowship at the MD Anderson Cancer Center in Houston, Texas.

Dr. Spiess has published over 180 peer-reviewed manuscripts and has edited 5 textbooks in urologic oncology. Dr. Spiess sits on several international editorial boards including Urologic Oncology: Seminars and Original Investigations (2013), British Journal of Medicine and Medical Research (2012), and the International Brazilian Journal of Urology (2017).

Dr. Spiess currently serves as the vice-chair of the NCCN panel for bladder and penile cancer. Heavily engaged in both fundamental and clinical kidney, penile, and bladder cancer research, Dr. Spiess has developed international multi-institution study collaborations which have re-defined the therapeutic approach to metastatic and locally advanced genitourinary cancers. In this regard, Dr. Spiess has been invited to speak on penile cancer as a leading expert internationally including Brazil, Canada, China, Mexico, and Peru.

We are excited to have Dr. Spiess in the position to build on the work of past editors and to add brilliance to AMJ, and for the journal to reach new heights.


Acknowledgements

None.


Footnote

Conflicts of Interest: The authors have no conflicts of interest to declare.

doi: 10.21037/amj.2020.02.10
Cite this article as: Editorial Office. AMJ New Editor-in-Chief Announcement. AME Med J 2020;5:1.